Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature
- PMID: 33637068
- PMCID: PMC7908689
- DOI: 10.1186/s12887-021-02556-9
Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature
Abstract
Background: Gliosarcoma is a rare variant of IDH- wild type glioblastoma with both glial and mesenchymal differentiation. It accounts for approximately 2% of glioblastomas and has a poor prognosis similar to that of classic glioblastoma. It is seen mostly between 40 and 60 years of age with a mean age over 50 years. Pediatric gliosarcoma is even rarer than gliosarcoma in adults. We describe the clinicopathological features of gliosarcoma in patients under 20 years of age and determine whether there are significant differences from gliosarcoma in adults. We also present detailed review of published literature on pediatric gliosarcoma.
Methods: Slides of gliosarcomas in patients under 20 years of age were reviewed. Clinicopathological features were noted in detail and follow up was obtained.
Results: Eleven cases of gliosarcoma were reported in patients under 20 years of age. Ages ranged from three to 19 years (mean age 13 years). Frontal, parietal and temporal lobes were the commonest locations. Mean and median tumor size was six and five cm respectively. All 11 cases demonstrated the classic biphasic pattern. In 10 cases, glial component was astrocytic and was highlighted on GFAP. Sarcomatous component in most cases resembled fibrosarcoma and was high grade in 72.7%. Glial areas were reticulin poor while sarcomatous areas were reticulin rich. In over 45% cases, bizarre tumor giant cells were seen in the sarcomatous areas. In 1 case, sarcomatous areas showed extensive bone and cartilage formation. Other histologic features included hyalinized blood vessels, hemorrhage, infarction, gemistocytic cells, rhabdoid cells etc. Follow up was available in nine patients, five received chemoradiation post resection while three received radiotherapy only. Prognosis was dismal and eight patients died within one to 14 months following resection.
Conclusions: Gliosarcomas in patients under 20 comprised 13% of all gliosarcomas reported during the study period. Frequency and mean age were higher compared to other published reports. Pathological features were similar to those described in literature. Clinicopathological features and prognosis of pediatric gliosarcomas were similar to adult gliosarcomas.
Keywords: Astrocytic; Biphasic; Cerebral hemispheres; Glial; Glioblastoma; Gliosarcoma; Mesenchymal; Pediatric.
Conflict of interest statement
It is declared that all authors have no conflict of interest.
Figures




Similar articles
-
Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.Am J Surg Pathol. 2007 Mar;31(3):351-62. doi: 10.1097/01.pas.0000213378.94547.ae. Am J Surg Pathol. 2007. PMID: 17325476
-
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.J Neurosurg. 1998 Sep;89(3):425-30. doi: 10.3171/jns.1998.89.3.0425. J Neurosurg. 1998. PMID: 9724117 Clinical Trial.
-
[Gliosarcoma of cerebral hemispheres: a clinicopathologic study of 10 cases].Zhonghua Bing Li Xue Za Zhi. 2014 Oct;43(10):657-62. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 25567590 Chinese.
-
Gliosarcoma with osteosarcomatous features: a short illustrated review.Acta Neurochir (Wien). 2009 Jul;151(7):809-13; discussion 813. doi: 10.1007/s00701-009-0341-2. Epub 2009 Apr 28. Acta Neurochir (Wien). 2009. PMID: 19399365 Review.
-
Gliosarcomas with the BRAF V600E mutation: a report of two cases and review of the literature.J Clin Pathol. 2017 Dec;70(12):1079-1083. doi: 10.1136/jclinpath-2017-204620. Epub 2017 Aug 3. J Clin Pathol. 2017. PMID: 28775171 Review.
Cited by
-
Pediatric gliosarcoma, a rare central nervous system tumor in children: Case report and literature review.Heliyon. 2023 Oct 22;9(11):e21204. doi: 10.1016/j.heliyon.2023.e21204. eCollection 2023 Nov. Heliyon. 2023. PMID: 37954329 Free PMC article.
-
Computed Tomography, Magnetic Resonance Imaging, and Pathological Features of Gliosarcoma.Neuropsychiatr Dis Treat. 2022 Nov 4;18:2577-2589. doi: 10.2147/NDT.S386616. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36387942 Free PMC article.
-
Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers.Int J Mol Sci. 2024 Jan 22;25(2):1335. doi: 10.3390/ijms25021335. Int J Mol Sci. 2024. PMID: 38279335 Free PMC article. Review.
-
Optic Pathway-Hypothalamic Glioma Apoplexy: A Report of Two Cases and Systematic Review of the Literature.Front Surg. 2022 May 30;9:891556. doi: 10.3389/fsurg.2022.891556. eCollection 2022. Front Surg. 2022. PMID: 35733436 Free PMC article. Review.
References
-
- Burger PC, Giangaspero F, Ohgaki H, Bieruat W, et al. Gliosarcoma. In: Louis DN, Ohgaki H, WK WODC, Ellison DW, Figarella–Branger D, Perry A, et al., editors. WHO Classification of Tumours of the Central Nervous System. Revised 4th Edition. International Agency for Research on Cancer (IARC) Lyon. 2016. pp. 48–49.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous